Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis | MicrobiomeTrials← Back to trialsNCT06855056
Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis
CompletedOBSERVATIONAL
Trial Details
Start: 2025-03-01Est. Completion: 2026-07-01
Enrollment target: 189 participants Locations- Hospital Beaujon, Clichy, France
- University Hospital, Aachen, Aachen, Germany
- Universitätsklinikum Münster, Münster, Germany
- IRCCS Azienda Ospedaliero Universitaria di Bologna Policlinico di S.Orsola, Bologna, Italia, Italy
- A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy
- Hospital Universitari Vall d'Hebron Research Institute, Barcelona, Spain
- Hospital Clinic de Barcelona, Barcelona, Spain
- Hospital Universitario Ramon y Cajal, Madrid, Spain
- Royal Free Hospital, London, United Kingdom
Other microbiome trials you might be interested in
Hematopoietic Stem Cell Transplant
Background:
Hematopoietic stem cell transplant (HSCT) is a common treatment for many cancers and other illnesses. But m…
Bethesda, United StatesEst. completion Jun 30, 2031
Cirrhosis, LiverSplenectomy; StatusRenal Function AbnormalPortal Hypertension
Patients with liver cirrhosis and portal hypertension often have impaired kidney function due to reduced blood flow to t…
Multiple LocationsCompleted Feb 2026